Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression

Therapeutic Drug Monitoring

Volumn 32, Issue 6, 2010, Pages 704-707

  Ilett, Kenneth F ^a,c   Watt, Felice ^b   Hackett, L Peter ^c   Kohan, Rolland ^b   Teoh, Stephanie ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

^c Path West Laboratory Medicine   (Australia)

Author keywords

amisulpride; breastfeeding; desvenlafaxine; infant dose

Indexed keywords

AMISULPRIDE; CITALOPRAM; DESVENLAFAXINE; DIAZEPAM; IMIPRAMINE; LORAZEPAM; MIRTAZAPINE; QUETIAPINE;

ADULT; ANXIETY DISORDER; ARTICLE; BREAST FEEDING; CASE REPORT; CLINICAL ASSESSMENT; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MILK LEVEL; DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; LACTATION; MAJOR DEPRESSION; MENTAL DISEASE; MILK; MORNING DOSAGE; PLASMA; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIDEPRESSIVE AGENTS; BREAST FEEDING; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LACTATION; MILK, HUMAN; SULPIRIDE;

EID: 78649444889     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181f88f70     Document Type: Article

References (20)

1. Hedlund PB. The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl). 2009;206:345-354.
2. Abbas AI, Hedlund PB, Huang XP, et al. Amisulpride is a potent 5-HT7 antagonist: releVance for antidepressant actions in vivo. Psychopharma-cology (Berl). 2009;205:119-128.
3. Hale TW. Medications and Mothers' Milk, 11th ed. Amarillo, TX: Pharmasoft Publishing; 2010:1-938.
4. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
5. Ilett KF, Hackett LP, Dusci LJ, et al. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol. 1998;45:459-462.
6. Ilett KF, Kristensen JH, Hackett LP, et al. Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br J Clin Pharmacol. 2002;53:17-22.
7. Newport DJ, Ritchie JC, Knight BT, et al. Venlafaxine in human breast milk and nursing infant plasma: determination of exposure. J Clin Psychiatry. 2009;70:1304-1310.
8. Hendrick V, Altshuler L, Wertheimer A, et al. Venlafaxine and breastfeeding. Am J Psychiatry. 2001;158:2089-2090.
9. Teoh S, Ilett KF, Hackett LP, et al. Estimation of rac-amisulpride transfer into milk and estimation of infant dose via milk during its use in a lactating woman with bipolar disorder and schizophrenia. Breastfeeding Med. October 6, 2010 [epub ahead of print].
10. Anonymous.Pristiq Product Information. TGA Approval 16/12/2009. Wyeth Australia Pty Ltd, Baulkham Hills, Australia, 1-15. 2010. Wyeth Australia Pty Ltd, Baulkham Hills, Australia. 12-3-2010.
11. Frankenburg WK, Dodds J, Archer P, et al. The Denver II: a major revision and restandardization of the Denver Developmental Screening Test. Pediatrics. 1992;89:91-97.
12. Thomann P. Non-compartmental analysis methods manual. In: Heinzel G, Woloszcak R, Thomann P, eds. TopFit 2.0 Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC. Stuttgart: Gustav Fischer; 1993:5-66.
13. Lucas A, Gibbs JA, Lyster RL, et al. Creamatocrit: simple clinical technique for estimating fat concentration and energy value of human milk. Br Med J (Clin Res Edn). 1978;1:1018-1020.
14. Bennett PN. Use of the monographs on drugs. In: Bennett PN, ed. Drugs and Human Lactation, 2nd ed. Amsterdam: Elsevier; 1996:67-74.
15. WHO Multicentre Growth Reference Study Group. WHO child growth standards based on length/height, weight and age. Acta Paediatrica. 2006; Suppl 450:76-85.
16. Baumann P, Hiemke C, Ulrich S, et al. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry. 2004;37:243-265.
17. Baselt RC. Venlafaxine. In: Baselt RC, ed. Disposition of Toxic Drugs and Chemicals in Man, 6th ed. Foster City, CA: Biomedical Publications; 2005:1084-1085.
18. Anderson BJ, Holford NH. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet. 2009;24:25-36.
19. Begg EJ. Instant Clinical Pharmacology, 1st ed. Oxford, UK: Blackwell Publishing Ltd; 2003:34-35.
20. Rampono J, Simmer K, Ilett KF, et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry. 2009;42: 95-100.